Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Department of Health and Human Services
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.
Funding
Award size
$100K – $1M
Award ceiling
750000
Type
Grant
Dates
Deadline
Later
Posted
10/22/2024
Closes
2027-10-20
Eligibility
Eligibility
Native American tribal governments (Federally recognized)Private institutions of higher educationState governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)For profit organizations other than small businessesPublic housing authorities/Indian housing authoritiesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationCity or township governmentsNative American tribal organizations (other than Federally recognized tribal governments)County governmentsIndependent school districtsSpecial district governmentsSmall businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPublic and State controlled institutions of higher education
Program
Funding area
Health - HL
Opportunity #
PAR-25-059
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov